Related Experiment Video
Updated: Apr 24, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines
Mary Ella M Pierpont1, Pilar L Magoulas2, Saleh Adi3
1Division of Genetics and Metabolism, Department of Pediatrics and Ophthalmology, and Children's Hospitals and Clinics of Minnesota, Saint Paul, Minnesota; pierp001@umn.edu.
Insights
Cardio-facio-cutaneous (CFC) syndrome, a RASopathy, shares features with Noonan and Costello syndromes. This consensus conference established clinical management guidelines for accurate diagnosis and comprehensive care of CFC patients.
Area of Science:
- Genetics and Molecular Biology
- Pediatrics
- Clinical Medicine
Background:
- Cardio-facio-cutaneous (CFC) syndrome is a rare genetic disorder.
- It is part of the RASopathy group, sharing features with Noonan and Costello syndromes.
- CFC syndrome is characterized by craniofacial abnormalities, heart defects, skin issues, growth delays, and intellectual disability.
Purpose of the Study:
- To establish clinical management guidelines for Cardio-facio-cutaneous syndrome.
- To improve the diagnosis and care of individuals with CFC syndrome.
- To provide a resource for healthcare professionals managing CFC syndrome.
Main Methods:
- A consensus conference was organized by CFC International.
- Experts from various medical specialties participated.
- Clinical management guidelines were developed based on expert consensus.
Main Results:
- The conference provided comprehensive clinical management guidelines for CFC syndrome.
- These guidelines aim to assist in accurate diagnosis and best practice recommendations.
- The guidelines facilitate long-term medical care for affected individuals.
Conclusions:
- Accurate diagnosis and multidisciplinary care are crucial for managing CFC syndrome.
- The developed guidelines will support healthcare providers in managing CFC patients.
- These guidelines are essential for improving outcomes and support for individuals with CFC syndrome.
Abstract:
Cardio-facio-cutaneous syndrome (CFC) is one of the RASopathies that bears many clinical features in common with the other syndromes in this group, most notably Noonan syndrome and Costello syndrome. CFC is genetically heterogeneous and caused by gene mutations in the Ras/mitogen-activated protein kinase pathway. The major features of CFC include characteristic craniofacial dysmorphology, congenital heart disease, dermatologic abnormalities, growth retardation, and intellectual disability. It is essential that this condition be differentiated from other RASopathies, as a correct diagnosis is important for appropriate medical management and determining recurrence risk. Children and adults with CFC require multidisciplinary care from specialists, and the need for comprehensive management has been apparent to families and health care professionals caring for affected individuals. To address this need, CFC International, a nonprofit family support organization that provides a forum for information, support, and facilitation of research in basic medical and social issues affecting individuals with CFC, organized a consensus conference. Experts in multiple medical specialties provided clinical management guidelines for pediatricians and other care providers. These guidelines will assist in an accurate diagnosis of individuals with CFC, provide best practice recommendations, and facilitate long-term medical care.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cardiomyopathy VI: Nursing Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Acute Coronary Syndrome IV: Interprofessional Care
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies